InvestorsHub Logo
Followers 16
Posts 1135
Boards Moderated 0
Alias Born 11/21/2017

Re: None

Monday, 12/02/2019 8:00:50 AM

Monday, December 02, 2019 8:00:50 AM

Post# of 731862
I’m frustrated with the lack of progress towards data in our trial. There is further progress to be made with other cancers using this platform. I spent last night getting one of my final visits with my aunt, who has advanced metastatic triple negative breast cancer. It was caught at stage 0 back in 2008 and she had surgery, chemo, and radiation back then. Eleven years later, it will kill her. I think it would be worth it to add DCVAX for patients like her when they’re stage 0 to find out if we can get a long survival tail, but it would probably take a 20 year trial. I hope someday the economics of drug development supports this work. This is where there is progress to be made in cancer treatment.

Our society throw plenty of money at this disease. It’s frustrating that one of our most promising technologies can’t be explored further due to poor market capitalization of the company that owns it.

Let’s get this trial unblinded and the results analyzed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News